The WRND ETF is designed to track the performance of the New York Life Global Equity R&D Leaders Index, before fees and expenses. The index focuses on selecting global equities of companies that use R&D investment consistently and allocate capital efficiently.

It treats R&D capability as an important driver of growth, which makes it suitable for long-term investors who want diversified exposure to a global group of innovative companies rather than to a single country or industry.

The ETF is passively managed (index-tracking) by New York Life Investment Management.

The New York Life Global Equity R&D Leaders Index starts from a broad global equity universe and evaluates both the consistency of R&D investment and capital efficiency. Rather than looking only at the size of R&D spending, it examines how likely that spending is to translate into investment results, and it adjusts its holdings according to its rules.

• A combination of R&D and capital efficiency
• Rules-based selection from a global equity universe

Assets under management (AUM) stand at $9.9M, and the total expense ratio is 0.18% per year.

Before trading, it is advisable to check the bid-ask spread and trading volume, and to compare the total expense ratio with those of alternative products in the same category.

The performance of the WRND ETF can be affected by investor appetite for growth stocks, earnings outlooks for innovation-related companies, and changes in interest rates. Companies with a large R&D component may show strong momentum when expectations rise, but volatility can increase when earnings expectations are revised, so investors should consider the diversification benefit rather than judging by the trend alone.

Fund flows may vary with global risk appetite and demand for growth-stock investments. If the market views R&D investment and productivity improvements favorably, interest may increase, but interest rates, exchange rates, and geopolitical variables can widen performance gaps across countries and industries.

A rule that looks at R&D and capital efficiency together is a strength, but investors should watch for the growth-stock character and the volatility that comes with global market variables.

Among the products shown in the table, the FNDF ETF takes a fundamental approach to international equities, the IGF ETF provides global infrastructure exposure, and the GUNR ETF covers the natural resources value chain, so their strategies differ from that of the WRND ETF. The GSIE ETF is characterized by a factor-based approach to international equities, and the GNR ETF by its weighting in global natural resources. When reviewing the WRND ETF, it is therefore worth comparing its R&D-focused selection with each product's fees and distribution characteristics.

Before investing, it is worth checking whether the R&D-focused selection fits your asset allocation goals and how much global equity and growth-stock exposure you already hold. The quarterly distribution structure is only a cash flow element and does not replace total return and risk, so trading costs and currency effects should also be reviewed.

If the market's assessment of R&D investment and growth expectations changes, price swings in the underlying holdings can grow. Because this is a global investment product, exchange rates, regional economic changes, the policy environment, and geopolitical variables can also affect performance measured in Korean won. Investors should also keep in mind that a quarterly distribution does not mean principal protection or stable returns.

The WRND ETF can be a candidate for investors who want rules-based exposure focused on global innovative companies' use of R&D and their capital efficiency. However, it is advisable to compare your existing growth-stock weighting, the nature of the quarterly distributions, and the fees and trading conditions, and then decide in line with your own risk tolerance.